Low-Dose Lectin Composition for Efficacy With Fewer Side Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing lectin compositions for cancer treatment and drug side effect management suffer from high doses leading to intolerances and side effects, negatively impacting patient compliance and therapy success.
Innovation Solution
A lectin composition with reduced doses (0.2 to 0.04 mg daily) combined with selenium, proteolytic enzymes, and other additives, formulated in various forms for oral administration, minimizing side effects while maintaining efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high doses of lectins (5-100 mg daily) are administered, then therapeutic efficacy is improved, but side effects and intolerances increase
Solution Approach 1:
The patent applies parameter changes by optimizing the lectin dosage to a specific range (0.5-10 mg daily, preferably 1-5 mg) rather than using high doses (5-100 mg). This dosage optimization resolves the contradiction by finding the optimal parameter value that provides sufficient therapeutic efficacy while minimizing side effects and intolerances
2Reliability
If high doses of lectins are used, then treatment results improve, but patient compliance decreases due to intolerances
Solution Approach 1:
By changing the dosage parameter to an optimized range (0.5-10 mg daily), the patent simultaneously improves patient compliance and maintains treatment results, resolving the contradiction between efficacy and ease of operation
3Reliability
If lectin concentration is increased, then effectiveness improves, but side effects increase
Solution Approach 1:
The patent optimizes the lectin concentration parameter to a specific range that maximizes effectiveness while minimizing harmful side effects, directly resolving the contradiction between these two opposing factors
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a composition comprising at least one lectin-containing lentil extract and/or lectin-containing pea extract, wherein the lentil lectin and/or pea lectin content is 0.1 to 0.03 mg, preferably 0.2 to 0.04 mg, particularly preferably 0.5 to 0.08 mg, and optionally further additives and excipients.